- today
Several studies involving CJC-1295 + DAC have shown promising results regarding the increase of hGH (human Growth Hormone) in both men and women. The results were so good in fact that CJC-1295 + DAC is pretty much the equivalent to Modified GRF 1-29. Here are some of the findings of the studies involving CJC-1295 + DAC, so that you can judge for yourself.
CJC-1295 + DAC study conducted in 2004, involved men and also produced similar results to Modified GRF 1-29. There was a 200% increase in the IGF-1 and hGH levels, So not only does it increase the hGH level, it also increases the substrate required for the anabolic reactions to occur. Which basically means that more hGH can be utilized, which means muscle hypertrophy occurs faster, all that happened while abdominal fat was reduced.
And Another Study.
Based on a 2006 CJC-1295 + DAC study, the peptide showed its potential as a long-term simulator of both the IGF-1 and hGH levels. The study indicated an increase in hGH anywhere from 200% up to 1000%, and this after a single daily injection for six days. Remember CJC-1295 + DAC half-life is extremely long consequently the hGH level remained higher than normal for up to a month in healthy test subjects aged between 21 and 61.
Knowing that this peptide has a long half-life, which eliminates the threat of food interactions that might reduce its efficacy, making it a convenient alternative to Modified GRF 1-29. Clinical studies in which CJC-1295 + DAC have been used claimed the peptide’s effectiveness, but experts do not recommend using this peptide for more than 6 months without taking some time off to avoid damaging the pituitary gland. These peptides have been used in the scientific field for quite many years now and are relatively safe.
Warning
THE GOODS OFFERED BY THE SELLER IS INTENDED FOR SCIENTIFIC AND DEVELOPMENT PURPOSES ONLY. The goods offered by the Seller include chemical substances that shall not be used as a drug, medicine, active substance, medical aid, cosmetic product, a substance for production of a cosmetic product neither for human consumption that is any food or food supplement or otherwise similarly used on humans or animals.
References / Links
- Teichman SL, Neale A, Lawrence B, Gagnon C, Castaigne JP, Frohman LA, Harman SM, Thorner MO. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab. 2006 Dec;91(12):799–805. PubMed
- Teichman SL, Neale A, Lawrence B, Gagnon C, Castaigne JP, Frohman LA, Harman SM, Thorner MO. Pharmacokinetic and pharmacodynamic properties of CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Pharmacol. 2004;44(12):1362–70. PubMed
- Sun Y, Wang P, Zheng H, Smith RG. Comparison of the pharmacological characteristics of CJC-1295 and growth hormone-releasing hormone (1–29) in rat pituitary cells. Endocrinology. 2004;145(12):5800–7. PubMed
- Thorner MO. Clinical review: hGH and growth hormone secretagogues: new therapeutic uses. J Clin Endocrinol Metab. 2009;94(10):3537–44. PubMed
